Understanding Trends and Challenges in the Behavioral Health Sector
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 200: Athlete Mental Health and Physical Conditioning With Dawn Staley
AGG Talks: Healthcare Insights Podcast - Episode 4: What to Do When Insurance Companies Deny Behavioral Health Claims
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 189: Student Mental Health with Dr. Stephanie Irby Coard, UNC Professor
What's the Tea in L&E? Is Your Workplace "Toxic?" Best Practices for Psychological Safety
Addiction and the Recovery Journey for Lawyers | Brian Cuban | Texas Appellate Law Podcast
Employee Assistance Programs & Career Balance – IMS Insights Podcast Episode 60
Mental Health in the Legal Field – IMS Insights Podcast Episode 59
Talking About Mental Health at Work – IMS Insights Podcast Episode 58
#WorkforceWednesday: Mental Health Awareness Month in the Workplace - Employment Law This Week®
Legal’s Mental Health Imperative
Compliance Into The Weeds - Mental Health and Compliance Officers
Responding to Trauma in the Workplace with Katharine Manning, President of Blackbird DC: On Record PR
What Can the Show Severance Teach Us About Work-Life Balance? - Hiring to Firing Podcast
A Slow Burn or a Burn Out: How to Know When You Are Past Your Limits
Taking the Pulse, A Health Care and Life Sciences Podcast | Episode 105: Sara Goldsby, Director, DAODAS
#WorkforceWednesday: Federal Focus on Mental Health, FTC and Noncompetes, Gig Work Risks for Hospitals - Employment Law This Week®
“Walking the Walk” on Lawyer Well-Being | Bree Buchanan
DE Under 3: EEOC & DOJ Technical Guidance for Employer’s AI Use; Upcoming EEOC Hearing; Event for Mental Health in the Workplace
DE Under 3: Best Practices, Webinars & Communication – Straight from Government Agencies
Research into psychedelic-assisted therapy receives funding in the National Defense Authorization Act for Fiscal Year 2024. In an epoch marked by rapid innovation in mental health treatments, a paradigm shift is on the...more
Ketamine clinics have been on the rise in the U.S. in recent years. As a byproduct of the common practice of prescribing drugs “off-label,” these clinics are not necessarily new in their operating model. Off-label use is the...more
On June 23, 2023, FDA issued a first-of-its-kind draft guidance for sponsors of studies of psychedelic drugs. The guidance arrived just as the Psychedelic Science 2023 conference in Denver was wrapping up. Touted as the...more